天目药业龙虎榜数据（8月21日）

Group 1 - Tianmu Pharmaceutical (600671) experienced a decline of 5.81% today, with a turnover rate of 17.79% and a trading volume of 409 million yuan, showing a fluctuation of 17.74% [2] - The stock was listed on the Shanghai Stock Exchange due to its daily fluctuation value reaching 17.74%, with a total net sell of 55.03 million yuan from brokerage seats [2] - The top five brokerage seats accounted for a total transaction of 131 million yuan, with a buying amount of 37.90 million yuan and a selling amount of 92.93 million yuan, resulting in a net sell of 55.03 million yuan [2] Group 2 - The main buying brokerage was Goldman Sachs (China) Securities, with a purchase amount of 10.49 million yuan, while the largest selling brokerage was Guotou Securities, with a selling amount of 30.50 million yuan [2] - The stock saw a net outflow of 39.47 million yuan in main funds today, including a net outflow of 7.07 million yuan from large orders and 32.39 million yuan from major funds, with a total net outflow of 20.80 million yuan over the past five days [2] - On April 28, the company reported a first-quarter revenue of 52.29 million yuan, representing a year-on-year growth of 88.55%, and a net profit of 5.09 million yuan, reflecting a year-on-year increase of 152.40% [2] Group 3 - On July 15, the company released a half-year performance forecast, expecting a net profit between 8.50 million yuan and 10.50 million yuan, with a year-on-year change range of 145.94% to 156.75% [3] - The trading data on August 21 showed that the top buying brokerages included Goldman Sachs (China) Securities and others, with significant buying amounts [3][4] - The selling brokerages included Guotou Securities and others, with notable selling amounts, indicating active trading behavior [4]